Lunai Bioworks Inc.
LNAI
Last
$1.19
Day
+6.3%
1y
-88.7%
5y
-98.1%
52w
-91.6%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-1333d
EMA 21
1.65
EMA 50
2.02
EMA 200
5.87
20d high
-58.1%
5y high
-99.7%
5y range
0th
Positions held
Your positionsLNAI isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-24
Hold
avoid
Signal
Strong Sell
Target
$1.52
Stop
$0.78
Stop distance
34.5%
Target vs last
+27.7%
Fundamentals
| Market cap | $5.08M | Enterprise value | $3.33M | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | -0.52 | Beta | 0.35 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 100.0% | Operating margin | -68.2% |
| Profit margin | 0.0% | ROE | -3.3% | ROA | -9.6% | Debt / equity | — |
| Current ratio | 0.19 | Free cash flow | -$6.96M | Analyst recommendation | none | Mean target | — |
| 52w high | $13.28 | 52w low | $1.08 |
Quarterly
| 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Op margin | -6815.3% | — | — | — | — |
| Net income | -$2.6M | -$1.8M | $2.8M | -$127M | $0.2M |
| Gross margin | 100.0% | — | — | — | — |
| Gross profit | $0.0M | — | — | — | $0.0M |
| Operating income | -$1.4M | -$1.8M | -$2.5M | -$4.1M | -$4.2M |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M |
| Op margin | — | — | — | — |
| Net income | -$178M | -$88.4M | -$39.7M | -$113M |
| Gross margin | — | — | — | — |
| Gross profit | — | $0.0M | $0.0M | — |
| Operating income | -$18.5M | -$27.4M | -$19.6M | -$22.8M |
Headline scan
Headline risk — review
• [CRITICAL · integrity] Lunai Bioworks (Nasdaq: LNAI) Names 10 Defendants in Naked Short Selling Fraud Suit
News
2026-09-22 · Lunai Bioworks (NASDAQ: LNAI) Expands Parkinson's Platform Through Exclusive Tanaist Agreement
2026-09-16 · Lunai Bioworks (Nasdaq: LNAI) Demonstrates AI Chemical-Risk Screening for Generative AI
2026-08-27 · Lunai Bioworks (Nasdaq: LNAI) Names Six Broker-Dealers in Expanded Naked Short Selling Suit
2026-08-04 · Lunai Bioworks (Nasdaq: LNAI) Names 10 Defendants in Naked Short Selling Fraud Suit
Price (daily)
Full chart · RSI · MACD · patternsLNAI · daily-49.8% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin